Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1)

Cell Growth and Differentiation

Volumn 10, Issue 2, 1999, Pages 93-100

  Gutterman, Jordan U ^a   Choubey, Divaker ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOPROTEIN; PROTEIN KINASE; PROTEIN P21;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMATION; ENZYME ACTIVITY; GENETIC TRANSFECTION; GROWTH RETARDATION; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION;

ANIMALS; BLOTTING, NORTHERN; CARRIER PROTEINS; CELL CYCLE; CELL DIVISION; CELL LINE; CYCLIN A; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; FIBROBLASTS; FLOW CYTOMETRY; HISTONES; HUMANS; INTERFERON-ALPHA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICROSCOPY, FLUORESCENCE; PHOSPHOPROTEINS; RETINOBLASTOMA PROTEIN; TETRACYCLINE; TIME FACTORS; TRANSFECTION;

ANIMALIA;

EID: 0032963397     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Pestka, S., Larger, J. A., Zoon, K. C., and Samuel, C. E. Interferons and their actions. Anna Rev. Biochem., 56: 727-777, 1987.
2. De Maeyer, E., and De Maeyer-Guignard, J. (eds.) Interferons and Other Regulatory Cytokines. New York: Wiley & Sons, 1988.
3. Sen, G. C., and Lengyel, P. The interferon system: a bird's eye view of its biochemistry. J. Biol. Chem., 267: 5017-5020, 1992.
4. Gutterman, J. U. Cytokine therapeutics: lessons from interferon a. Proc. Natl. Acad. Sci. USA, 97: 1198-1202, 1994.
5. Borden, E. C. Interferons. In: J. F. Holland, R. C. Bast, Jr., D. L. Morton, E. Frei III, D. W. Kufe, and R. R. Weichselbaum (eds.), Cancer Medicine, Vol. 1, pp. 1199-1212. Baltimore, MD: Williams & Wilkins Press, 1997.
6. Choubey, D., Snoddy, J., Chaturvedi, V., Toniato, E., Opdenakker, G., Thakur, A., Samanta, H., Engel, D., and Lengyel, P. Interferons as gene activators: indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome 1. J. Biol. Chem., 264: 17182-17189, 1989.
7. Choubey, D., and Lengyel, P. Interferon action: cytoplasmic and nuclear localization of the interferon-inducible 52-kD protein that is encoded by the Ifi 200 gene from the gene 200 cluster. J. Interferon Res., 73:43-52, 1993.
8. Lengyel, P., Choubey, D., Li, S-J., and Datta, B. The interferon-activatable gene 200 cluster: from structure toward function. Semin. Virol., 6: 203-213, 1995.
9. Choubey, D., and Gutterman, J. U. The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domain. Biochem. Biophys. Res. Commun., 221: 396-401, 1996.
10. Koul, D., Lapushin, R., Xu, H-J., Gutterman, G. U., Mills, G. B., and Choubey, D. p202 self-associates through a sequence conserved among the members of the 200-family proteins. FEBS Lett., 438: 21-24, 1998.
11. Choubey, D., and Lengyel, P. Binding of an interferon-inducible protein (p202) to the retinoblastoma protein. J. Biol. Chem., 270: 6134-6140, 1995.
12. Choubey, D., Li, S. J., Datta, B., Gutterman, J. U., and Lengyel, P. Inhibition of E2F-mediated transcription by p202. EMBO J., 15: 5668-5678, 1996.
13. Min, W., Ghosh, S., and Lengyel, P. The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-κB, c-Fos, and c-Jun activities. Mol. Cell. Biol., 16: 359-368, 1996.
14. Koul, D., Lapushin, R., Xu, H-J., Mills, G. B., Gutterman, G. U., and Choubey, D. p202 prevents apoptosis in murine AKR-2B fibroblasts. Biochem. Biophys. Res. Commun., 247: 379-382, 1998.
15. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
16. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
17. Xiong, Y., Hannon, G. J, Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
18. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211: 90-98, 1994.
19. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
20. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, J. W., Elledge, S. J., and Reed, S. I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G, arrest. Cell, 76: 1013-1023, 1994.
21. CIP1/WAF1 undergo normal development, but are defective in G, checkpoint control. Cell, 82: 675-684, 1995.
22. 1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
23. 2/M-phase transition. Mol. Cell. Biol., 78: 546-557, 1998.
24. 1S transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol., 78: 629-643, 1997.
25. Sheikh, M. S., Li, X. S., Chen, J. C., Shao, G. M., Ordonez, J. V., and Fontana, J. A. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene, 9: 3407-3415, 1994.
26. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994
27. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
28. Cip1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.
29. Ogryzko, V. V., Wong, P., and Howard, B. H. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol. Cell. Biol., 77: 4877-4882, 1997.
30. Hobeika, A. C., Subramaniam, P. S., and Johnson, H. M. IFN-α induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells. Oncogene, 14: 1165-1170, 1997.
31. Sangfelt, O., Erickson, S., Einhorn, S., and Grander, D. Induction of Cip/Kip and Ink4 cyclin-dependent kinase inhibitors by interferon-α in hematopoietic cell lines. Oncogene, 14: 415-423, 1997.
32. 1 cell cycle arrest mediated by the Type-1 interferons. J. Interferon Cytokine Res., 17: 11-15, 1997.
33. 1 cells arrested with α-interferon. Oncogene, 7: 783-788, 1992.
34. Resnitzky, D., Tiefenbrun, N., Berissi, H., and Kimchi, A. Interferons and interleukin-6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc. Natl. Acad. Sci. USA, 89: 402-406, 1992.
35. Arany, I. Rady, P., and Tyring, S. K. Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF β1/IFN-β cytokine pathway. Antiviral Res., 23: 131-141, 1994.
36. Pfeffer, L. M., Murphy, J. S., and Tamm, I. Interferon effects on the growth and division of human fibroblasts. Exp. Cell Res., 121: 111-120, 1979.
37. Gossen, M., and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 89: 5547-5551, 1992.
38. Gartel, A. L., Serfas, M. S., and Tyner, A. L. p21-negative regulator of the cell cycle. Proc. Natl. Acad. Sci. USA, 213: 138-149. 1996.
39. Zetterberg, A., Larsson, O., and Wiman, K. G. What is the restriction point? Curr. Opin. Cell Biol., 7: 835-842, 1995.
40. Datta, B., Li, B., Choubey, D., Nallur, G., and Lengyel, P. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition. J. Biol. Chem., 271: 27544-27557, 1996.
41. Choubey, D., and Gutterman, J. U. Inhibition of E2F-4/DP-1-stimulated transcription by p202. Oncogene, 15: 291-302, 1997.
42. Fan, J., and Bertino, J. R. Functional roles of E2F in cell cycle regulation. Oncogene, 14: 1191-1200, 1997.
43. DeGregori, J., Leone, G., Miron. A., Jakoi, L., and Nevins, J. R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA, 94: 7245-7250, 1997.
44. Kumar, R., and Atlas, I. Interferon a induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation. Proc. Natl. Acad. Sci. USA, 89: 6599-6603, 1992.
45. Livneh, E., Shimon, T., Bechor, E., Doki, Y., Schieren, I., and Weinstein, I. B. Linking protein kinase C to the cell cycle: ectopic expression of PKCn in NIH3T3 cells alters the expression of cyclins and Cdk inhibitors and induces adipogenesis. Oncogene, 12: 1545-1555, 1996.
46. WAF1/CIP1/SDI1 mRNA and protein expression upon genotoxic stress. Oncogene, 17: 781-787, 1998.
47. WAF1. Mol. Cell. Biol., 18: 459-467, 1998.
48. Timchenko, N. A., Harris, T. E., Wilde, M., Bilyeu, T. A., Burgess-Beusse, B. L., Finegold, M. J., and Darlington, G. J. CCMT/enhancer binding protein a regulates p21 protein and hepatocyte proliferation in newborn mice. Mol. Cell. Biol., 17: 7353-7361, 1997.
49. Dimri, G. P., Nakanishi, M., Desprez, P. Y., Smith, J. R., and Campisi, J. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol. Cell. Biol., 16: 2987-2997, 1996.
50. Shiyanov, P, Bagchi, S., Adami, G., Kokontis, J., Hay, N., Arroyo, M., Morozov, A., and Raychaudhuri, P. p21 Disrupts the interaction between cdk2 and the E2F-p130 complex. Mol. Cell. Biol., 16: 737-744, 1996.
51. WAF1/ Cip in human brain tumors. Oncogene, 11: 2021-2028, 1995.
52. Hiyama, H., lavarone, A., LaBaer, J., and Reeves, S. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p27 gene without altering cell cycle progression. Oncogene, 14: 2533-2542, 1997, 1997.
53. 1/S transition in human papillomavirus type 16 E7 expressing human cells is associated with altered regulation of cyclin E. J. Virol., 72: 975-985, 1998.
54. 1 cyclin-dependent Kinase activity. Genes Dev., 9: 2873-2887, 1995.
55. Johnson, D. G., Schwartz, J. K., Cress, W. D., and Nevins, J. R. Expression of transcription factor E2F-1 induces quiescent cells to enter S phase. Nature (Lond.), 365: 349-352, 1993.
56. Hiyama, H., lavarone, A., and Reeves, S. A. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene, 16: 1513-1523, 1998.
57. (INK4d) and cyclin D2 expression. J. Biol. Chem., 273: 11799-11805, 1998.
58. Resnitzky, D., Gossen, M., Bujard, H., and Reed, S. I. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol., 14: 1669-1679, 1994.
59. Chen, C., and Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7: 2745-2752, 1987.
60. Sambrook, J., Fritch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989.
61. Choubey, D., and Lengyel, P. Interferon action: nucleolar and nucleoplasmic localization of the interferon-inducible 72-kD protein that is encoded by the Ifi 204 gene from the gene 200 cluster. J. Cell Biol., 116: 1333-1341, 1992.